Top Markets
Coin of the day
Predilife S.A. Predilife S.A.

Predilife S.A.

ALPRE
Rank in Stocks #18209
Predilife S.A. develops and sells medical techniques and mathematical models.... Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
Share Price
$1.71
Market Cap
$6.73M
Change (1 day)
-4.00%
Change (1 year)
-61.64%
Country
FR
Trade Predilife S.A. (ALPRE)

Category

Revenue for Predilife S.A. (ALPRE)
Revenue in Dec 2025 TTM: $1.31M
According to Predilife S.A. latest financial reports the company's current revenue (TTM) is $1.31M. In 2023 the company made a revenue of $351.31K an increase over the revenue in the year 2022 that was $309.58K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Predilife S.A. from 2016 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $1.31M 103.93%
2024 $643.13K 83.07%
2023 $351.31K 13.48%
2022 $309.58K 91.60%
2021 $161.57K 157.25%
2020 $62.81K 144.75%
2019 $25.66K -69.09%
2018 $83.04K 64.75%
2017 $50.40K 598,648.91%
2016 $8.42 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$45.20B 3,446,019.39%
US
$24.78B 1,889,139.25%
US
$6.99B 532,702.35%
CN
$4.45B 338,899.80%
US
$2.50B 190,587.28%
US